First National Bank of Omaha Has $708,000 Position in Stryker Corporation (SYK)

First National Bank of Omaha decreased its position in shares of Stryker Corporation (NYSE:SYK) by 38.4% during the second quarter, Holdings Channel reports. The fund owned 5,105 shares of the medical technology company’s stock after selling 3,180 shares during the period. First National Bank of Omaha’s holdings in Stryker Corporation were worth $708,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Aperio Group LLC raised its position in Stryker Corporation by 10.7% in the second quarter. Aperio Group LLC now owns 181,504 shares of the medical technology company’s stock worth $25,189,000 after buying an additional 17,554 shares during the last quarter. Wendell David Associates Inc. raised its position in Stryker Corporation by 0.9% in the second quarter. Wendell David Associates Inc. now owns 135,740 shares of the medical technology company’s stock worth $18,838,000 after buying an additional 1,196 shares during the last quarter. Louisiana State Employees Retirement System raised its position in Stryker Corporation by 1.1% in the second quarter. Louisiana State Employees Retirement System now owns 19,200 shares of the medical technology company’s stock worth $2,665,000 after buying an additional 200 shares during the last quarter. Smithbridge Asset Management Inc. DE raised its position in Stryker Corporation by 1.0% in the second quarter. Smithbridge Asset Management Inc. DE now owns 13,928 shares of the medical technology company’s stock worth $1,933,000 after buying an additional 140 shares during the last quarter. Finally, Baltimore Washington Financial Advisors Inc. raised its position in Stryker Corporation by 3.3% in the second quarter. Baltimore Washington Financial Advisors Inc. now owns 64,687 shares of the medical technology company’s stock worth $8,977,000 after buying an additional 2,051 shares during the last quarter. 74.26% of the stock is owned by hedge funds and other institutional investors.

Stryker Corporation (NYSE:SYK) traded up 2.60% during mid-day trading on Friday, reaching $147.80. 1,927,066 shares of the company traded hands. The stock’s 50-day moving average price is $142.41 and its 200-day moving average price is $133.92. The firm has a market cap of $55.26 billion, a PE ratio of 32.99 and a beta of 0.79. Stryker Corporation has a one year low of $106.48 and a one year high of $148.15.

Stryker Corporation (NYSE:SYK) last issued its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.02. The company had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.58%. The company’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.39 EPS. Analysts forecast that Stryker Corporation will post $6.43 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 31st. Stockholders of record on Friday, June 30th will be paid a $0.425 dividend. This represents a $1.70 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Wednesday, June 28th. Stryker Corporation’s dividend payout ratio (DPR) is presently 37.95%.

TRADEMARK VIOLATION NOTICE: “[[title]]” was first posted by [[site]] and is owned by of [[site]]. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at [[permalink]].

A number of research firms have issued reports on SYK. Stifel Nicolaus boosted their target price on shares of Stryker Corporation from $151.00 to $158.00 and gave the company a “buy” rating in a research note on Friday. Oppenheimer Holdings, Inc. set a $148.00 target price on shares of Stryker Corporation and gave the company a “hold” rating in a research note on Friday. Royal Bank Of Canada boosted their target price on shares of Stryker Corporation from $140.00 to $155.00 and gave the company an “outperform” rating in a research note on Friday. Zacks Investment Research lowered shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Thursday. Finally, BMO Capital Markets reissued a “hold” rating and set a $140.00 target price on shares of Stryker Corporation in a research note on Tuesday, July 11th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $143.34.

In other news, insider David Floyd sold 19,305 shares of the firm’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $144.56, for a total value of $2,790,730.80. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Timothy J. Scannell sold 13,322 shares of the firm’s stock in a transaction dated Tuesday, May 2nd. The shares were sold at an average price of $135.89, for a total transaction of $1,810,326.58. The disclosure for this sale can be found here. Insiders sold a total of 40,008 shares of company stock worth $5,669,088 in the last ninety days. Insiders own 7.40% of the company’s stock.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).